These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23587702)

  • 21. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
    Miyazaki T; Kohno S
    Expert Rev Anti Infect Ther; 2015; 13(9):1171-83. PubMed ID: 26089168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D; Depestel DD; Carver PL
    Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of antifungal resistance and its impact on clinical practice.
    Alcazar-Fuoli L; Mellado E
    Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Training should be the first step toward an antifungal stewardship program.
    Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Mousset S; Buchheidt D; Heinz W; Ruhnke M; Cornely OA; Egerer G; Krüger W; Link H; Neumann S; Ostermann H; Panse J; Penack O; Rieger C; Schmidt-Hieber M; Silling G; Südhoff T; Ullmann AJ; Wolf HH; Maschmeyer G; Böhme A
    Ann Hematol; 2014 Jan; 93(1):13-32. PubMed ID: 24026426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases.
    Nami S; Aghebati-Maleki A; Morovati H; Aghebati-Maleki L
    Biomed Pharmacother; 2019 Feb; 110():857-868. PubMed ID: 30557835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated guidelines for managing fungal diseases in hematology patients.
    Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing invasive fungal infection in hematopoietic stem-cell transplantation.
    Sinkó J; Bryan J
    Future Microbiol; 2010 Sep; 5(9):1309-14. PubMed ID: 20860477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination antifungal therapy: the new frontier.
    Vazquez JA
    Future Microbiol; 2007 Apr; 2(2):115-39. PubMed ID: 17661650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention, diagnosis, and treatment of invasive fungal infections in patients with cancer and neutropenia.
    Cumbo TA; Segal BH
    J Natl Compr Canc Netw; 2004 Sep; 2(5):455-69. PubMed ID: 19780254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of documented and suspected neutropenia-associated invasive fungal infections.
    De Pauw BE
    J Chemother; 2001 Nov; 13 Spec No 1(1):181-92. PubMed ID: 11936364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination antifungal therapy: what can and should we expect?
    Johnson MD; Perfect JR
    Bone Marrow Transplant; 2007 Aug; 40(4):297-306. PubMed ID: 17563740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
    Leroux S; Ullmann AJ
    Clin Microbiol Infect; 2013 Dec; 19(12):1115-21. PubMed ID: 24118188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
    Strasfeld L; Weinstock DM
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
    Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.